For practitioner dispensing and professionally guided use.
Always read the label and follow the directions for use.
Contraindicated during pregnancy.
Use during breastfeeding is not recommended unless specifically reviewed and prescribed by a qualified healthcare practitioner.
Corydalis may cause drowsiness, dizziness, weakness or reduced alertness in some individuals.
Avoid driving or operating machinery if affected.
Consult your healthcare practitioner before combining Corydalis with sleeping medicines, sedating medicines, strong pain medicines, alcohol or other products that may cause drowsiness.
Consult your healthcare practitioner before use if you take prescription medication or have an existing medical condition.
Seek professional advice before use if you have liver disease, abnormal liver test results or a history of medicine- or herb-related liver reactions.
Do not use this product as a substitute for medical assessment or prescribed treatment of persistent pain, severe menstrual pain, nerve pain, injury, unexplained swelling or significant bruising.
Seek urgent medical attention for sudden severe pain, chest pain, severe abdominal or pelvic pain, neurological symptoms, major trauma or pain accompanied by fever, fainting or breathing difficulty.
Persistent or worsening menstrual pain, unusually heavy bleeding or bleeding between periods requires medical assessment.
Discontinue use at least seven days before general anaesthesia unless otherwise directed by your healthcare professional.
Stop use and seek advice if excessive drowsiness, dizziness, weakness, yellowing of the skin or eyes, dark urine or another unexpected reaction occurs.
Contains 45% ethanol.
Keep out of reach of children.
Corydalis safety data remain limited. Reported concerns include sedation, dizziness and potential toxicity associated with its alkaloid constituents, while published reviews of herb-induced liver injury have also identified Corydalis yanhusuo among implicated herbs.